Source: craftcannabiscollection.ca
  • Mr. Terry Wang and Mr. Leon Jiao have been appointed to the company’s board of directors
  • Mr. Wang was recently appointed as the company’s Interim CEO
  • Mr. Jiao brings valuable marketing, customer service and facility oversight skills to Benchmark Botanics
  • Mr. Haifeng Liu resigned as the company’s President and board director
  • Ms. Jin Kuang CPA, CGA, is replacing David Li as Chief Financial Officer
  • Potanicals Green Growers, a wholly-owned subsidiary of Benchmark, and a joint venture partner completed a second facility, a 4-acre Greenhouse Operation in Pitt Meadows, BC
  • Benchmark Botanics Inc. is a licensed producer of medical dried cannabis 
  • Benchmark Botanics, Inc (BBT) is up 16.67 per cent, trading at C$0.105 per share at 2:30 pm ET

Benchmark Botanics, Inc (BBT) has added two new directors to its board.

Mr. Terry Wang and Mr. Leon Jiao have been appointed to the company’s board of directors.

Mr. Wang was recently appointed as the company’s Interim CEO.

Mr. Jiao, currently the CFO and director of a wine and spirits company, brings valuable marketing, customer service and facility oversight skills to Benchmark Botanics. Mr. Jiao holds a BA degree from Simon Fraser University.

Mr. Haifeng Liu resigned as the company’s President and board director. The company wishes to thank Mr. Liu for his many valuable contributions, vision and dedication to Benchmark and wishes him the best in his future endeavours.

Mr. David Li has resigned as the Chief Financial Officer. Ms. Jin Kuang CPA, CGA, Benchmark’s Financial Controller, has been appointed Chief Financial Officer.

Benchmark’s 100% owned subsidiary, Potanicals Green Growers Inc. is a Health Canada licensed producer under the Cannabis Act and its regulations. 

As part of its expansion strategy, Potanicals Green Growers and a joint venture partner completed a second facility, a 4-acre Greenhouse Operation in Pitt Meadows, BC. The company, through Potanicals, received its second cultivation license, effective November 29, 2019, from Health Canada for the Pitt Meadows greenhouse.

Benchmark is a diversified multi-licensed cannabis producer focused on a three-way vertical business model targeting the medical and recreational markets in Canada.

Benchmark Botanics, Inc (BBT) is up 16.67 per cent, trading at C$0.105 per share at 2:30 pm ET.

More From The Market Herald

The Market Herald’s Weekly Cannabis Report – Dec. 8, 2023

Investors in the cannabis industry have had their eyes on Canopy Growth stock, considering its potential for growth and profitability.

Buzz on the Bullboards: Who’s taking off and who’s grounded

As everyone races toward the finish line, let’s take a look at some of the stocks that are standing out from the rest.

Cannara reports record growth and profitability in Q4 2023

Cannabis producer Cannara Biotech Inc. (TSXV:LOVE) reported record growth and profitability in its Q4 and 2023 fiscal year results.

Will Canopy Growth stock recover?

Cannabis Investors have had their eyes on Canopy Growth (TSX:WEED) stock, considering its potential for growth and profitability.